2025
Schneider P, Salcher-Konrad M (2025): Internationale Preisanalyse von Medikamenten im patentabgelaufenen Markt. Gesundheit Österreich. Vienna
2024
Windisch F, Zimmermann N, Knoll V et al. (2024): Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market. Final report. Publications Office of the European Union. https://data.europa.eu/doi/10.2925/210943
2023
Salcher‐Konrad M, Knoll V, Vogler S (2023): Leistungsspektrum der öffentlichen Apotheken im österreichischen Gesundheitssystem – Bestandsaufnahme, Analyse und Ausblick. Wissenschaftlicher Bericht. (in German with an English short summary, title in English: Review and analysis of services provided by community pharmacies in Austria). Vienna: Gesundheit Österreich (GÖG / Austrian National Public Health Institute)
Fischer S, Knoll V, Alleweldt F, Vogler S (2023): Potential measures to facilitate the production of active pharmaceutical ingredients (APIs). Study requested by the European Parliament's Committee on the Environment, Public Health and Food Safety
2022
Vogler S, Salcher-Konrad M, Habimana K (2022): Study on best practices in the public procurement of medicines: final report. European Commission, European Health and Digital Executive Agency: Publications Office of the European Union, https://data.europa.eu/doi/10.2925/044781
Annexes were published in 2023 and are available at: https://op.europa.eu/en/publication-detail/-/publication/c941de60-0417-11ee-87ec-01aa75ed71a1/language-en and https://op.europa.eu/en/publication-detail/-/publication/7c128a82-0418-11ee-87ec-01aa75ed71a1/language-en/format-PDF/source-search
Steigenberger C, Vogler S, Windisch F, Zimmermann N (2022). Recommendations for innovative fit for purpose pricing and funding models for CA-ARTI diagnostics. VALUE Dx
Windisch F, Habl C (2022): EURIPID Feasibility study for the integration of medical devices into EURIPID. Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Vienna
Vogler S (2022): Access to information in markets for medicines in the WHO European Region. Oslo Medicines Initiative technical report. Copenhagen: World Health Organization, Regional Office for Europe
Vogler S (2022): Payer policies to support innovation and access to medicines in the WHO European Region. Copenhagen: World Health Organization, Regional Office for Europe
Webb E, Richardson E, Vogler S, Panteli D (2022): What are the implications of policies increasing transparency of prices paid for pharmaceuticals. World Health Organization, European Observatory on Health Systems and Policies
2021
Vogler S, Schneider P, Fischer S, Haasis MA, Heindl B, Windisch F (2021): Preisvergleich ausgabenstarker Arzneispezialitäten 2019. (in German with an English short summary, title in English: Price comparison of high-cost medicines). Gesundheit Österreich, Vienna
Fischer S, Vogler S, Windisch F, Zimmermann N (2021): HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI. VALUE-Dx
Vogler S, Habimana K, Bauer E, Schneider P, Haasis MA (2021): Assessment of Centralised Procurement of Medicines in Portugal - Full Report. Gesundheit Österreich, Vienna
Vogler S, Habimana K, Bauer E, Schneider P, Haasis MA (2021): Assessment of Centralised Procurement of Medicines in Portugal - Summary Report. Gesundheit Österreich, Vienna
Vogler S, Habimana K, Bauer E, Schneider P, Haasis MA (2021): Avaliação das Aquisições centralizadas dos medicamentos em Portugal – Relatório de Síntese. Gesundheit Österreich, Vienna
Vogler S, Habimana K, Fischer S, Haasis MA (2021): Novel policy options for reimbursement, pricing and procurement of AMR health technologies. Gesundheit Österreich, Vienna
2020
Vogler S, Zimmermann N, Dedet G, Lam J, Bak Pedersen H (2020): Pharmaceutical Pricing and Reimbursement Systems in Eastern Europe and Central Asia. WHO Regional Office for Europe, Copenhagen
Vogler S, Zimmermann N, Dedet G, Lam J, Bak Pedersen H (2020): Pharmaceutical Pricing and Reimbursement Systems in Eastern Europe and Central Asia (in Russian). WHO Regional Office for Europe, Copenhagen
Vogler S, Haasis MA, van den Ham R, Suleman F, Humbert T, Garner S (2020): Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region. WHO Regional Office for Europe, Copenhagen
Vogler S, Fischer S (2020): Lieferengpässe bei Arzneimitteln: Internationale Evidenz und Empfehlungen für Deutschland. Kurzgutachten. (in German with an English short summary, title in English: Medicine shortages: international evidence and recommendations for Germany).Gesundheit Österreich, Wien
2019
Vogler S, Zimmermann N, Haasis MA (2019): PPRI Report 2018 - Pharmaceutical pricing and reimbursement policies in 47 PPRI network member countries. WHO Collaborating Centre for Pricing and Reimbursement Policies, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Vienna
2018
Zimmermann N, Zuba M (2018): Arzneimittelausgaben pro Kopf im internationalen Vergleich (in German with an English short summary, title in English: An international comparison of pharmaceutical expenditure per capita). Gesundheit Österreich, Wien
Vogler S, Haasis MA, Dedet G, Lam J, Bak Pedersen H (2018): Medicines reimbursement policies in Europe. WHO Regional Office for Europe, Copenhagen
Schneider P, Vogler S, Zimmermann N, Zuba M (2018): Preisvergleich ausgabenstarker Arzneispezialitäten 2017 - Wissenschaftlicher Ergebnisbericht (in German; Title in English: Price comparison of high-cost pharmaceuticals). Gesundheit Österreich, Wien
Schneider P, Vogler S, Zimmermann N, Zuba M (2018): Preisvergleich ausgabenstarker Arzneispezialitäten 2017 - Kurzbericht (in German; Title in English: Price comparison of high-cost pharmaceuticals - Short Report). Gesundheit Österreich, Wien
Schneider P, Vogler S, Zimmermann N, Zuba M (2018): Price comparison of high-cost medicines 2017 – Brief report in English. Gesundheit Österreich, Vienna
Habl C, Schneider P, Sebesta R, Nemeth G (2018): Euripid Guidance Document External Reference Pricing (ERP). Written as part of the Project ‘664317 / Statistical data for medicinal product pricing EU-RIPID’ which has received funding from the European Union’s Health Programme (2014-2020)
Zuba M, Habl C, Nemeth G (2018): EURIPID Study on the Calculation of Purchasing Power Parities (PPPs) for pharmaceutical products. Written in the framework of Contract N°: PN5C/06/2016/C4 supported by Eurostat
Vogler S, Paris V, Panteli D (2018): Policy Brief: Ensuring access to medicines: How to redesign pricing, reimbursement and procurement?. European Observatory on Health Systems and Policies of the WHO Regional Office for Europe
2017
Schneider P, Habl C (2017): EURIPID - Best Practice Report on External Reference Pricing (ERP). Written by Gesundheit Österreich Forschungs- und Planungs GmbH, as part of the Project ‘664317 / Statistical data for medicinal product pricing EU-RIPID’ which has received funding from the European Union’s Health Programme (2014-2020), 2017, Vienna
Zimmermann N, Habimana, K (2017): Arzneimittelausgaben in Österreich (in German with an English short summary, title in English: Pharmaceutical expenditure in Austria). Gesundheit Österreich, Vienna.
2016
Vogler S, Lepuschütz L, Schneider P, Stühlinger V (2016): Study on enhanced cross-country coordination in the area of pharmaceutical product pricing. Written by Gesundheit Österreich Forschungs- und Planungs GmbH, University for Health Sciences, Medical Informatics and Technology (UMIT) and SOGETI. Funded by the Health Programme of the European Union, Vienna
Vogler S, Lepuschütz L, Schneider P, Stühlinger V (2016): Deutsche Kurzfassung (German Executive Summary) zur Studie "Study on enhanced cross-country coordination in the area of pharmaceutical product pricing". Written by Gesundheit Österreich Forschungs- und Planungs GmbH, University for Health Sciences, Medical Informatics and Technology (UMIT) and SOGETI. Funded by the Health Programme of the European Union, Wien
Vogler S, Schneider P, Zimmermann N (2016): Price comparison of high-cost medicines 2015 among European Union Member States (in German with Executive Summary in English). Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health and Women's Affairs, Vienna
Vogler S, Schneider P, Zimmermann N (2016): Price comparison of high-cost medicines 2015 among European Union Member States (Brief Report in English). Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health and Women's Affairs, 2016, Vienna
Panteli D, Arickx F, Cleemput I, Dedet G, Eckhardt H, Fogarty E, Gerkens S, Henschke C, Hislop J, Jommi C, Kaitelidou D, Kawalec P, Keskimäki I, Kroneman M, Lopez Bastida J, Pita Barros P, Ramsberg J, Schneider P, Spillane S, Vogler S, Vuorenkoski L, Wallach Kildemoes H, Wouters O, Busse R (2016): Pharmaceutical regulation in 15 European countries: Review. Health Systems in Transition, 18(5): 1–118
Schneider P, Vogler S (2016): Pharmaceutical pricing and reimbursement reform in Kyrgyzstan. WHO Regional Office for Europe, 2016, Copenhagen
Schneider P, Vogler S.: Pharmaceutical pricing and reimbursement reform in Kyrgyzstan (In Russian). WHO Regional Office for Europe, Copenhagen
Kaplan W, Wirtz V, Nguyen A, Ewen M, Vogler S, Laing R (2016): Policy Options for Promoting the Use of Generic Medicines in Low and Middle-income Countries. Health Action International
2015
Ostermann H, Renner A, Bobek J, Schneider P, Vogler S (2015): A cost/benefit analysis of self-care systems in the European Union. Written by Gesundheit Österreich Forschungs- und Planungs GmbH and SOGETI. Funded by the Health Programme of the European Union, Vienna
2014
Vogler S, Zimmermann N, Habimana (2014): Study of the policy mix for the reimbursement of medicinal products. Proposal for a best practice-based approach based on stakeholder assessment. Written by Gesundheit Österreich Forschungs- und Planungs GmbH and SOGETI. Funded by the Health Programme of the European Union, Vienna
Vogler S, Habimana K (2014): Pharmaceutical pricing policies in European countries. Written by Gesundheit Österreich Forschungs- und Planungs GmbH, commissioned by CtW Investment Group, Vienna
Vogler S, Zimmermann N, Habl C (2014): Comparison of prices of 30 high-cost medicines in Austria and 15 European countries (in German). Written by Gesundheit Österreich, Vienna
2012
Vogler S, Arts D, Sandberger K (2012): Impact of pharmacy deregulation and regulation in European countries. Full report; Written by Gesundheit Österreich Forschungs- und Planungs GmbH, commissioned by Danmarks Apotekerforening (Association of Danish Pharmacies), Vienna
Vogler S, Arts D, Sandberger K (2012): Impact of pharmacy deregulation and regulation in European countries. Summary Report. Written by Gesundheit Österreich Forschungs- und Planungs GmbH, commissioned by Danmarks Apotekerforening (Association of Danish Pharmacies), Vienna
Vogler S (2012) Auswirkungen von Deregulierung und Regulierung im Apothekenwesen. Untersuchung in neun europäischen Ländern. Fact Sheet. [German Fact Sheet accompanying the study "Impact of pharmacy deregulation and regulation in European countries"] Written by Gesundheit Österreich Forschungs- und Planung GmbH, Vienna
Vogler S (2012): Arzneimittelmanagement in Krankenanstalten. Ergebnisse der europaweiten PHIS-Studie. Fact Sheet. [German Fact Sheet accompanying the PHIS Hopsital Pharma report] Written by Gesundheit Österreich, Vienna
2011
Habl C, Bachner F (2011): Initial investigation to assess the feasibility of a coordinated system to access orphan medicines. Written by Gesundheit Österreich GmbH, commissioned by the European Commission, Directorate-General Enterprise, Vienna
Vogler S, Leopold C, Zimmermann N (2011): PHIS Hospital Pharma. Arzneimittelmanagement in Krankenanstalten. Pharmaceutical Health Information System; Written by Gesundheit Österreich GmbH, commissioned by the Executive Agency for Health and Consumers and the Austrian Federal Ministry of Health, Vienna
2010
Leopold C, Rovira J, Habl C (2010): Generics in small markets or for low volume medicines European Union: Evidence from the Netherlands, Germany and Belgium. Written by Gesundheit Österreich GmbH, commissioned by the European Commission, Directorate-General Enterprise, Vienna
Vogler S, Habl C, Leopold C, Morak S, Mazag J, Zimmermann N (2010): PHIS Hospital Pharma Report . Pharmaceutical Health Information System; Written by Gesundheit Österreich GmbH, commissioned by the Executive Agency for Health and Consumers and the Austrian Federal Ministry of Health, Vienna
Habl C, Bachner F (2010): Das Österreichische Gesundheitssystem: Zahlen – Daten – Fakten. [Title in English: Measuring the performance of the Austrian Health System]; Commissioned by the Austrian Federal Ministry of Health, Vienna
Habl C, Bachner F (2010): Measuring the performance of the Austrian Health System. Commissioned by the Austrian Federal Ministry of Health, Vienna
Habl C, Bachner F (2010): Das österreichische Gesundheitswesen im internationalen Vergleich . Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health, Vienna
Vogler S, Schmickl B (2010): Rational Use of Medicines in Europe . Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health, Vienna
Vogler S, Schmickl B (2010): Rationale Arzneimitteltherapie in Europa . Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health, Vienna
Zuidberg C, Vogler S, Mantel-Teeuwisse A (2010): The pharmaceutical system of the Netherlands: A comparative analysis between the Dutch out-patient pharmaceutical system, in particular the pricing and reimbursement characteristics, and those of the other European Union Member States, with a special focus on tendering-like systems. Written by Gesundheit Österreich GmbH, compiled in the framework of the WHO Collaborating Centre of Pharmaceutical Pricing and Reimbursement Policies, Vienna
2009
Morak S, Vogler S, Walser S, Kijlstra N (2009): Health Systems: Policy aspects – Understanding the pharmaceutical care concept and applying it in practice. Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health and the Council of Europe, Vienna
2008
Leopold C, Habl C, Vogler S, Rosian-Schikuta I (2008): Steuerung des Arzneimittelverbrauchs am Beispiel Dänemark . Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health, Family and Youth, 2008, Vienna
Leopold C, Habl C, Morak S, Rosian- Schikuta I, Vogler S (2008): Leistungsfähigkeit des österreichischen Gesundheitssystems im Vergleich . Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health, Family and Youth, Vienna
Vogler S, Habl C, Leopold C, Rosian-Schikuta I, de Joncheere K, Lyager Thomsen T (2008): PPRI Report . Written by Gesundheit Österreich GmbH, commissioned by the European Commission, Directorate-General Health and Consumer Protection and Austrian Federal Ministry of Health, Family and Youth, Vienna
Weigl M, Antony K (2008): Arzneimittelsysteme in Bulgarien und Rumänien. Written by Gesundheit Österreich GmbH, commissioned by the Austrian Federal Ministry of Health, Family and Youth, Vienna
Habl C, Vogler S, Leopold C, Schmickl B, Fröschl B (2008): Referenzpreissysteme in Europa . Written by Gesundheit Österreich GmbH, commissioned by the Main Association of Austrian Social Security Institutions, Vienna
Habl C, Vogler S, Leopold C, Schmickl B, Fröschl B (2008): Reference price systems in Europe: Executive summary. Written by Gesundheit Österreich GmbH, commissioned by the Main Association of Austrian Social Security Institutions, Vienna
Leopold C, Habl C, Vogler S (2008): Tendering of Pharmaceuticals in EU Member States and EEA countries. Results from the country survey. Written by Gesundheit Österreich Forschungs- und Planungs GmbH, commissioned by the Main Association of Austrian Social Health Insurance Institutions (HVB) on behalf of the European Social Insurance Platform (ESIP), Vienna
2006
Vogler S, Habl C, Leopold C (2006): Pharmaceutical systems in the European Union 2006. Fact sheets. ÖBIG, Vienna
Vogler S, Habl C, Leopold C (2006): Pharmaceutical systems in the European Union 2006 - Comparative analysis. ÖBIG, Vienna
Vogler S, Arts D, Habl C (2006): Community Pharmacy in Europe. Lessons from deregulation - case studies. Commissioned by Pharmaceutical Group of the European Union. ÖBIG, Vienna
Arts D, Habl C, Schnabel E (2006): Nahtstellenmanagement bei Arzneimitteln. ÖBIG, Vienna
2005
Vogler S, Habl C, Leopold C (2005): Pharmaceutical systems in the new EU Member States. Commissioned by the Austrian Federal Ministry of Health and Women and the Main Association of Austrian Social Security Institutions, ÖBIG, Vienna
Vogler S, Habl C, Leopold C (2005): Arzneimittelsysteme in den neuen EU-Mitgliedstaaten. ÖBIG, Vienna
Habl C, Schnabel E, Vogler S (2005): Öffentliche Ausgaben für Prävention und Gesundheitsförderung in Österreich 2001. ÖBIG, Vienna
Habl C, Antony K, Arts D, Entleitner M, Fröschl B, Leopold C, Stürzlinger H, Vogler S, Weigl M (2005): Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States..Commissioned by European Commission - DG Competition, ÖBIG, Vienna
2004
Rosian I, Vogler S, Stürzlinger H (2004): Internationale Arzneimittelpreisvergleiche: Meta-Analyse. ÖBIG, Vienna
2003
Rosian I, Habl C (2003): Impfungen. Ökonomische Evaluation. ÖBIG, Vienna
Vogler S, Habl C (2003): Arzneimittel. Distribution in Skandinavien. ÖBIG, Vienna
Vogler S, Freihoff W (2003): Kostenfaktoren in der tierärztlichen Hausapotheke. ÖBIG, Vienna
Rosian I (2003): Selbstbeteiligung: Internationaler Vergleich und Implikation für Österreich. ÖBIG, Vienna
2001
Rosian I, Antony K, Habl C, Vogler S, Weigl M (2001): Arzneimittelausgaben: Strategien zur Kostendämpfung – Länderportraits. Commissioned by the Austrian Federal Ministry of Social Security and Generations, Vienna
Rosian I, Antony K, Habl C, Vogler S, Weigl M (2001): Benchmarking Pharmaceutical Expenditure: Cost-Containment Strategies in the European Union. ÖBIG, Vienna
Rosian I, Antony K, Habl C, Vogler S, Weigl M (2001): Benchmarking Arzneimittelausgaben – Kostendämpfungsstrategien in Europa. ÖBIG, Vienna
Rosian I, Vogler S (2001): Generika Modell Burgenland. Commissioned by the Austrian Generics Association, ÖBIG, Vienna
2000
Vogler S, Habl C (2000): Medikamente aus dem Internet. ÖBIG, Vienna
Vogler S, Habl C, Kranvogel-Zellermayer E, Rosian I (2000): Apothekenleistungen im europäischen Vergleich – Kurzzusammenfassung. ÖBIG, Vienna
Vogler S, Habl C (2000): E-Pharma. Arzneimittelvertrieb im Internet. ÖBIG, Vienna
Rosian I, Vogler S, Weigl M (2000): Generika. ÖBIG, Vienna
1999
Vogler S, Habl C (1999): Health Care System in Central and Eastern Europe. ÖBIG, Vienna
Vogler S, Habl C (1999): Gesundheitssysteme in Mittel- und Osteuropa. ÖBIG, Vienna
1998
Rosian I, Rohrbach C, Schindler E, Vogler S, Weigl M (1998). Biotechnologie: Pharmazeutische Industrie und Forschung in Österreich. ÖBIG.Vienna
Vogler S (1998): Arzneimittel: Vertrieb in Europa. ÖBIG, Vienna
Rosian I, Habl C, Vogler S (1998): Pharmaceuticals Market Control in Nine European Countries. ÖBIG, Vienna
1993
Hofmarcher M. M, Frank W, Rosian I, Theuer W, Beuren D, Ofner S (1993): International comparison of pharmaceutical prices. ÖBIG, Vienna